ALEX BRUMMER: Britain - despite its chaotic response and high death count - has done more than any other to meet the challenge of coronavirus
- The two most effective treatments for Covid-19, which have brought down death rates and eased the damage to patients, are products of UK scientists
- The fight attracts World War II metaphors. Out of chaos, ill preparation and retreat from Dunkirk, Britain triumphed
Here is something you are unlikely to hear on today's broadcast bulletins. Of all the countries fighting coronavirus, Britain – despite its chaotic response and high death count – has done more than any other to meet the challenge of the pandemic.
This is not my opinion but that of Tyler Cowen, an economist at George Mason University in Virginia, told to Bloomberg.
The UK has several factors working in its favour. Its liberal market economy may lack the discipline of co-ordinated market economies such as Germany but it is less constrained and more resilient.
Meeting the challenge: The two most effective treatments for Covid-19, which have brought down death rates and eased the damage to patients, are products of UK scientists
Early in the pandemic, Britain was less prepared than Germany. But once the private sector and universities were let loose, F1 engineers were building ventilators and University College London had come up with a lighter, less intrusive and more sensitive ventilator design.
Something else has gone largely unnoticed. The two most effective treatments for Covid-19, which have brought down death rates and eased the damage to patients, are products of UK scientists. It was British researchers who discovered that the most effective drug treatment was dexamethasone, a widely used steroid, which is low cost and widely available.
Moreover, scientists at the University of Southampton and their commercial spinout Synairgen found that their inhaled antiviral drug SNG001 significantly reduced the odds of patients hospitalised with Covid-19 coming down with respiratory disease. The first patient studies showed a remarkable 79 per cent effectiveness.
The vaccine picture also tilts in favour of the Anglo-Saxon liberal market model. Of the 34 vaccines identified by the WHO as being research tested and trialled, the vast majority (around 30) are emerging from the UK, US and other free-wheeling nations.
Only four so far can be attributed to the more static EU model. The Oxford Jenner vaccine, adopted by AstraZeneca (AZ), has led for much of this year. It was set back last week by an apparent adverse reaction in one UK female patient.
In keeping with principles of good research, AZ instantly paused its work before now restarting global trials.
The interruption was in line with a pledge made by big pharma companies to maintain the highest standards in the rush to finish line. AZ's vaccine progress and GlaxoSmithKline's adjuvant technology, expected to result in a vaccine in 2021, is a tribute to Britain's world-leading pharma and university labs.
So much world-leading science has found a home in the UK which hosts four out of the world's top 20 research universities. All of those – Oxford, Cambridge, UCL and Imperial (as well as Southampton) – have devoted enormous resources to Covid-19. With the assistance of extra R&D funding, they effectively have become the Bletchley Park in the war against pandemic.
What is impressive about the hunt for a vaccine is the speed. Cautious voices warn of a potential bad outcome as when a vaccine was rushed for H5N1 avian flu in 2003. Big pharma is determined not to abuse gateways offered by regulators to bring effective treatments to fruition.
The fight attracts World War II metaphors. Out of chaos, ill preparation and retreat from Dunkirk, Britain triumphed. Extraordinary efforts by science and pharma are making that happen again and, with medical resilience, will come an economic bounce. It is already happening.
Most watched Money videos
- The new Volkswagen Passat - a long range PHEV that's only available as an estate
- 'Now even better': Nissan Qashqai gets a facelift for 2024 version
- BMW's Vision Neue Klasse X unveils its sports activity vehicle future
- MG unveils new MG3 - Britain's cheapest full-hybrid car
- German car giant BMW has released the X2 and it has gone electric!
- Mini unveil an electrified version of their popular Countryman
- Steve McQueen featured driving famous stunt car in 'The Hunter'
- Skoda reveals Skoda Epiq as part of an all-electric car portfolio
- How to invest to beat tax raids and make more of your money
- Mail Online takes a tour of Gatwick's modern EV charging station
- Dacia Spring is Britain's cheapest EV at under £15,000
- Iconic Dodge Charger goes electric as company unveils its Daytona
- The luxury giant going for gold at the Paris Olympics -...
- Wall Street pins hopes on a set of upbeat results from...
- G7 fights for Ukraine cash as Russia's economy booms -...
- MARKET REPORT: Airlines soar as Easyjet eyes a record summer
- 888 shares rise as William Hill owner posts...
- Why is bitcoin halving this weekend? How the event could...
- 'I'm neither hero nor villain', insists disgraced fund...
- BUSINESS LIVE: Retail sales stagnate; 888 revenues beat...
- Hunt raises alarm over bid for Royal Mail as 'Czech...
- Two female BP execs to leave in first reshuffle since...
- I was left £5,000 short after 6 months waiting for state...
- Co-op Bank agrees possible £780m takeover by Coventry...
- Could the recent record rainfall leave our supermarket...
- My husband managed all my money. Now he's left me, what...
- Foxtons hails best under-offer homes pipeline since...
- Neil Woodford is back as a finfluencer: You may remember...
- Average car insurance bills rocket to almost £1,000:...
- Rentokil shares slip as investors mull mixed picture on...